Our patents
Hemarina was founded in 2007 with CNRS patent application WO2001/092320 (filed under number PCT/FR2001/001505). The corresponding titles were issued in 2002 for France and in 2004 for Europe, the CNRS granted Hemarina an exclusive license to operate this group of patents.
The company focuses its efforts on developing its fully patented product portfolio.
Today, its R&D developments are protected by no less than 17 different patent applications, the majority of which have been granted.
Hemarina strives to maximize collaborations with its partners, who constitute an important innovation resource, while maintaining absolute respect for the rights and properties of each.
Summary of patents granted & PENDING REQUESTS:
Entitled
Reference
Country
Use of a high molecular weight extracellular hemoglobin as a blood substitute.
WO2001/092320
Europe
Japan
Method for the dissociation of the extracellular haemoglobin molecule of Arenicola marina, characterization of the protein chains constituting said molecule and the nucleotide sequences encoding said protein chains.
WO2005/037392
Europe
USA
Canada
Use of haemoglobin for the preparation of dressings and resulting dressings.
WO2009/007532
Europe
USA
Canada
Use of a globin, a globin protomer or an extracellular hemoglobin for the preservation of organs, tissues, organ and tissue cells and cell cultures.
WO2009/050343
Europe
Hong-Kong
USA
Japan
Mexique
Canada
Novel Bioreactor using oxygen-carrying molecules.
WO2010/122080
Europe
USA
Novel heamoglobin and uses thereof.
WO2010/128159
Europe
USA
China
Organ-preserving composition and uses.
WO2013/001196
Europe
China
Mexique
Canada
USA
Use of annelid haemoglobin for maintaining stem cells in the undifferentiated state.
WO2013/030496
Europe
USA
China
Annelid haemoglobin lyophilisation process.
WO2013/182806
Europe
USA
China
Use of haemoglobin of annelids for treating cancers.
WO2014/125225
Europe
USA
Japan
Sand worm lyophilisate and uses therefore.
WO2014/184492
Europe
USA
China
Canada
Method for inducing sexual maturation of lugworms.
EP1679959 & US7568446
Europe
USA
Aquaculture of marine worms.
US7004109
USA
Use of hemoglobin from annelids as bactericide, in particular for preventing and/or treating a periodontal disease.
WO2019141744
Europe
USA
Mexico
Method for monitoring the viability of a graft.
WO2019201863
Europe
Brazil
India
USA
WO/2021/032763
Europe
Use of Haemoglobin from annelids for treating acute respiratory distress syndrome.
W02021/198336
Europe
